• 0
    Loading cart contents...
Search
CRE (Neo), CMV lentivirus
CRE (Neo), CMV lentivirus
LVP297
GenTarget 1x107 IFU/ml x 200ul
CRE stable cells with Neomycin marker
CRE stable cells with Neomycin marker
SC004-Neo
GenTarget 2 x 106 cell/ml x 1ml
CRE (Neo), CMV lentivirus, in PBS 
CRE (Neo), CMV lentivirus, in PBS 
LVP297-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE (Neo), EF1a lentivirus
CRE (Neo), EF1a lentivirus
LVP521
GenTarget 1x107 IFU/ml x 200ul
CRE (Neo), CAG lentivirus
CRE (Neo), CAG lentivirus
LVP575
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-GFP (Neo), CMV lentivirus
CRE-2A-GFP (Neo), CMV lentivirus
LVP408
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-RFP (Neo), CMV lentivirus
CRE-2A-RFP (Neo), CMV lentivirus
LVP027
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-GFP (Neo), CMV lentivirus in PBS 
CRE-2A-GFP (Neo), CMV lentivirus in PBS 
LVP408-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE-2A-RFP (Neo), CMV lentivirus in PBS 
CRE-2A-RFP (Neo), CMV lentivirus in PBS 
LVP027-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE (Neo), EF1a lentivirus, in PBS 
CRE (Neo), EF1a lentivirus, in PBS 
LVP521-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE (Neo), CAG lentivirus, in PBS
CRE (Neo), CAG lentivirus, in PBS
LVP575-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE (Bsd), CMV lentivirus
CRE (Bsd), CMV lentivirus
LVP336
GenTarget 1x107 IFU/ml x 200ul
CRE (Puro), CMV lentivirus
CRE (Puro), CMV lentivirus
LVP339
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-RFP (CMV-Neo), Ultra titer lentivirus
CRE-2A-RFP (CMV-Neo), Ultra titer lentivirus
ULVP-027
GenTarget 1 x109 IFU/ml x 50 ul
CRE-2A-GFP (CMV-Neo), Ultra titer lentivirus
CRE-2A-GFP (CMV-Neo), Ultra titer lentivirus
ULVP-408
GenTarget 1 x109 IFU/ml x 50 ul
CRE (Bsd), CMV lentivirus in PBS 
CRE (Bsd), CMV lentivirus in PBS 
LVP336-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE (Puro), CMV lentivirus in PBS 
CRE (Puro), CMV lentivirus in PBS 
LVP339-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE-2A-RFP (Neo), EF1a lentivirus
CRE-2A-RFP (Neo), EF1a lentivirus
LVP524
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-GFP (Neo), EF1a lentivirus
CRE-2A-GFP (Neo), EF1a lentivirus
LVP527
GenTarget 1x107 IFU/ml x 200ul
Luciferase-2A-CRE (Neo), lentiviral particles
Luciferase-2A-CRE (Neo), lentiviral particles
LVP410
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-RFP (Neo), EF1a lentivirus in PBS 
CRE-2A-RFP (Neo), EF1a lentivirus in PBS 
LVP524-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE-2A-GFP (Neo), EF1a lentivirus in PBS 
CRE-2A-GFP (Neo), EF1a lentivirus in PBS 
LVP527-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE stable cells with Blasticidin marker
CRE stable cells with Blasticidin marker
SC004-Bsd
GenTarget 2 x 106 cell/ml x 1ml
CRE stable cells with Puromycin marker
CRE stable cells with Puromycin marker
SC004-Puro
GenTarget 2 x 106 cell/ml x 1ml
CRE-2A-GFP, CMV lentivirus
CRE-2A-GFP, CMV lentivirus
LVP804
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-RFP, CMV lentivirus
CRE-2A-RFP, CMV lentivirus
LVP805
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-GFP, CMV lentivirus in PBS 
CRE-2A-GFP, CMV lentivirus in PBS 
LVP804-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE-2A-RFP, CMV lentivirus in PBS 
CRE-2A-RFP, CMV lentivirus in PBS 
LVP805-PBS
GenTarget 5 x107 IFU/ml x 200ul
Luciferase-2A-CRE (Neo), lentiviral particles, in vivo ready
Luciferase-2A-CRE (Neo), lentiviral particles, in vivo ready
LVP410-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE-2A-GFP (Bsd), CMV lentivirus
CRE-2A-GFP (Bsd), CMV lentivirus
LVP337
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-RFP (Puro), CMV lentivirus
CRE-2A-RFP (Puro), CMV lentivirus
LVP338
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-GFP (Puro), CMV lentivirus
CRE-2A-GFP (Puro), CMV lentivirus
LVP407
GenTarget 1x107 IFU/ml x 200ul
CRE-2A-RFP (Bsd), CMV lentivirus
CRE-2A-RFP (Bsd), CMV lentivirus
LVP013
GenTarget 1x107 IFU/ml x 200ul
CRE (CMV Promoter) Integrase-Deficient Lentivirus
CRE (CMV Promoter) Integrase-Deficient Lentivirus
IDLV025
GenTarget 1x10^7 IFU/ml x 200ul
CRE-2A-GFP (Bsd), CMV lentivirus in PBS 
CRE-2A-GFP (Bsd), CMV lentivirus in PBS 
LVP337-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE-2A-RFP (Puro), CMV lentivirus in PBS 
CRE-2A-RFP (Puro), CMV lentivirus in PBS 
LVP338-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE-2A-GFP (Puro), CMV lentivirus in PBS 
CRE-2A-GFP (Puro), CMV lentivirus in PBS 
LVP407-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE-2A-RFP (Bsd), CMV lentivirus in PBS 
CRE-2A-RFP (Bsd), CMV lentivirus in PBS 
LVP013-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE (Bsd), EF1a lentivirus
CRE (Bsd), EF1a lentivirus
LVP519
GenTarget 1x107 IFU/ml x 200ul
CRE (Puro), EF1a lentivirus
CRE (Puro), EF1a lentivirus
LVP520
GenTarget 1x107 IFU/ml x 200ul
CRE (Puro), CAG lentivirus
CRE (Puro), CAG lentivirus
LVP573
GenTarget 1x107 IFU/ml x 200ul
CRE (Bsd), CAG lentivirus
CRE (Bsd), CAG lentivirus
LVP574
GenTarget 1x107 IFU/ml x 200ul
CRE (Bsd), EF1a lentivirus in PBS 
CRE (Bsd), EF1a lentivirus in PBS 
LVP519-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE (Puro), EF1a lentivirus in PBS 
CRE (Puro), EF1a lentivirus in PBS 
LVP520-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE (Puro), CAG lentivirus in PBS
CRE (Puro), CAG lentivirus in PBS
LVP573-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE (Bsd), CAG lentivirus in PBS
CRE (Bsd), CAG lentivirus in PBS
LVP574-PBS
GenTarget 5 x107 IFU/ml x 200ul
CRE stable cells with GFP-Puromycin dual marker
CRE stable cells with GFP-Puromycin dual marker
SC004-GP
GenTarget 2 x 106 cell/ml x 1ml
CRE stable cells with RFP-blasticidin dual marker
CRE stable cells with RFP-blasticidin dual marker
SC004-RB
GenTarget 2 x 106 cell/ml x 1ml
CRE stable cells with RFP-Puromycin dual marker
CRE stable cells with RFP-Puromycin dual marker
SC004-RP
GenTarget 2 x 106 cell/ml x 1ml
CRE (GFP-Puro), CAG lentivirus
CRE (GFP-Puro), CAG lentivirus
LVP576
GenTarget 1x107 IFU/ml x 200ul